Nvidia Corp: Form 10-K for the period ended Jan 29, 2023
Filed with the SEC on Feb 24, 2023 and accepted by EDGAR at Feb 24, 2023, 17:23 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-01-29. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-01-31 to 2023-01-29 | $26.97bn | us-gaap:Revenues |
| Cost of revenue | 12 months2022-01-31 to 2023-01-29 | $11.62bn | us-gaap:CostOfRevenue |
| Gross profit | 12 months2022-01-31 to 2023-01-29 | $15.36bn | us-gaap:GrossProfit |
| Research and development | 12 months2022-01-31 to 2023-01-29 | $7.34bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2022-01-31 to 2023-01-29 | $2.44bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2022-01-31 to 2023-01-29 | $4.22bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2022-01-31 to 2023-01-29 | $262.0m | us-gaap:InterestExpense |
| Income tax | 12 months2022-01-31 to 2023-01-29 | −$187.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-01-31 to 2023-01-29 | $4.37bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2022-01-31 to 2023-01-29 | $1.74 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-01-31 to 2023-01-29 | $1.76 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-01-31 to 2023-01-29 | 2,507,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-01-31 to 2023-01-29 | $5.64bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 12 months2022-01-31 to 2023-01-29 | $398.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 12 months2022-01-31 to 2023-01-29 | $10.04bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-01-29 | $3.39bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-01-29 | $23.07bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-01-29 | $41.18bn | us-gaap:Assets |
| Current liabilities | At period end2023-01-29 | $6.56bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-01-29 | $19.08bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-01-29 | $9.70bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-01-29 | $1.25bn | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2023-01-29 | $0 | us-gaap:CommercialPaper |
| Shareholders' equity | At period end2023-01-29 | $22.10bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001045810-23-000017. Last ingested by Listed: Nov 12, 2026, 19:06 ET. Listed shows no prices and gives no investment advice.